Patents by Inventor Karola Wagner

Karola Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
    Patent number: 7851599
    Abstract: The invention refers to the use of L19IL2 for treatment of pancreatic cancer. In another embodiment, the invention relates to a combination (i) of a fusion protein, comprising an Interleukin 2 part and an antibody part, specifically recognizing the extra domain B of fibronectin (ED-B-fibronectin), and (ii) gemcitabine.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: December 14, 2010
    Assignee: Philogen S.p.A.
    Inventors: Andreas Menrad, Hans Dietrich Menssen, Karola Wagner
  • Combination of an anti-ED - B fibronectin domain antibody - IL-2 fusion protein and gemcitabine
    Publication number: 20090110660
    Abstract: The invention refers to the use of L19IL2 for treatment of pancreatic cancer. In another embodiment, the invention relates to a combination (i) of a fusion protein, comprising an Interleukin 2 part and an antibody part, specifically recognising the extra domain B of fibronectin (ED-B-fibronectin), and (ii) gemcitabine.
    Type: Application
    Filed: April 4, 2007
    Publication date: April 30, 2009
    Inventors: ANDREAS MENRAD, HANS DIETRICH MENSSEN, KAROLA WAGNER